Cargando…

Tumor Suppressor 4.1N/EPB41L1 is Epigenetic Silenced by Promoter Methylation and MiR-454-3p in NSCLC

Non–small-cell lung cancer (NSCLC) is divided into three major histological types, namely, lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), and large-cell lung carcinoma (LCLC). We previously identified that 4.1N/EPB41L1 acts as a tumor suppressor and is reduced in NSCLC patients. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Qin, Zhu, Lin, Ye, Mao, Zhang, Bin, Zhan, Peihe, Li, Hui, Zou, Wen, Liu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251189/
https://www.ncbi.nlm.nih.gov/pubmed/35795202
http://dx.doi.org/10.3389/fgene.2022.805960
_version_ 1784739982506721280
author Yang, Qin
Zhu, Lin
Ye, Mao
Zhang, Bin
Zhan, Peihe
Li, Hui
Zou, Wen
Liu, Jing
author_facet Yang, Qin
Zhu, Lin
Ye, Mao
Zhang, Bin
Zhan, Peihe
Li, Hui
Zou, Wen
Liu, Jing
author_sort Yang, Qin
collection PubMed
description Non–small-cell lung cancer (NSCLC) is divided into three major histological types, namely, lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), and large-cell lung carcinoma (LCLC). We previously identified that 4.1N/EPB41L1 acts as a tumor suppressor and is reduced in NSCLC patients. In the current study, we explored the underlying epigenetic mechanisms of 4.1N/EPB41L1 reduction in NSCLC. The 4.1N/EPB41L1 gene promoter region was highly methylated in LUAD and LUSC patients. LUAD patients with higher methylation level in the 4.1N/EPB41L1 gene promoter (TSS1500, cg13399773 or TSS200, cg20993403) had a shorter overall survival time (Log-rank p = 0.02 HR = 1.509 or Log-rank p = 0.016 HR = 1.509), whereas LUSC patients with higher methylation level in the 4.1N/EPB41L1 gene promoter (TSS1500 cg13399773, TSS1500 cg07030373 or TSS200 cg20993403) had a longer overall survival time (Log-rank p = 0.045 HR = 0.5709, Log-rank p = 0.018 HR = 0.68 or Log-rank p = 0.014 HR = 0.639, respectively). High methylation of the 4.1N/EPB41L1 gene promoter appeared to be a relatively early event in LUAD and LUSC. DNA methyltransferase inhibitor 5-Aza-2′-deoxycytidine restored the 4.1N/EPB41L1 expression at both the mRNA and protein levels. MiR-454-3p was abnormally highly expressed in NSCLC and directly targeted 4.1N/EPB41L1 mRNA. MiR-454-3p expression was significantly correlated with 4.1N/EPB41L1 expression in NSCLC patients (r = −0.63, p < 0.0001). Therefore, we concluded that promoter hypermethylation of the 4.1N/EPB41L1 gene and abnormally high expressed miR-454-3p work at different regulation levels but in concert to restrict 4.1N/EPB41L1 expression in NSCLC. Taken together, this work contributes to elucidate the underlying epigenetic disruptions of 4.1N/EPB41L1 deficiency in NSCLC.
format Online
Article
Text
id pubmed-9251189
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92511892022-07-05 Tumor Suppressor 4.1N/EPB41L1 is Epigenetic Silenced by Promoter Methylation and MiR-454-3p in NSCLC Yang, Qin Zhu, Lin Ye, Mao Zhang, Bin Zhan, Peihe Li, Hui Zou, Wen Liu, Jing Front Genet Genetics Non–small-cell lung cancer (NSCLC) is divided into three major histological types, namely, lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), and large-cell lung carcinoma (LCLC). We previously identified that 4.1N/EPB41L1 acts as a tumor suppressor and is reduced in NSCLC patients. In the current study, we explored the underlying epigenetic mechanisms of 4.1N/EPB41L1 reduction in NSCLC. The 4.1N/EPB41L1 gene promoter region was highly methylated in LUAD and LUSC patients. LUAD patients with higher methylation level in the 4.1N/EPB41L1 gene promoter (TSS1500, cg13399773 or TSS200, cg20993403) had a shorter overall survival time (Log-rank p = 0.02 HR = 1.509 or Log-rank p = 0.016 HR = 1.509), whereas LUSC patients with higher methylation level in the 4.1N/EPB41L1 gene promoter (TSS1500 cg13399773, TSS1500 cg07030373 or TSS200 cg20993403) had a longer overall survival time (Log-rank p = 0.045 HR = 0.5709, Log-rank p = 0.018 HR = 0.68 or Log-rank p = 0.014 HR = 0.639, respectively). High methylation of the 4.1N/EPB41L1 gene promoter appeared to be a relatively early event in LUAD and LUSC. DNA methyltransferase inhibitor 5-Aza-2′-deoxycytidine restored the 4.1N/EPB41L1 expression at both the mRNA and protein levels. MiR-454-3p was abnormally highly expressed in NSCLC and directly targeted 4.1N/EPB41L1 mRNA. MiR-454-3p expression was significantly correlated with 4.1N/EPB41L1 expression in NSCLC patients (r = −0.63, p < 0.0001). Therefore, we concluded that promoter hypermethylation of the 4.1N/EPB41L1 gene and abnormally high expressed miR-454-3p work at different regulation levels but in concert to restrict 4.1N/EPB41L1 expression in NSCLC. Taken together, this work contributes to elucidate the underlying epigenetic disruptions of 4.1N/EPB41L1 deficiency in NSCLC. Frontiers Media S.A. 2022-06-20 /pmc/articles/PMC9251189/ /pubmed/35795202 http://dx.doi.org/10.3389/fgene.2022.805960 Text en Copyright © 2022 Yang, Zhu, Ye, Zhang, Zhan, Li, Zou and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Yang, Qin
Zhu, Lin
Ye, Mao
Zhang, Bin
Zhan, Peihe
Li, Hui
Zou, Wen
Liu, Jing
Tumor Suppressor 4.1N/EPB41L1 is Epigenetic Silenced by Promoter Methylation and MiR-454-3p in NSCLC
title Tumor Suppressor 4.1N/EPB41L1 is Epigenetic Silenced by Promoter Methylation and MiR-454-3p in NSCLC
title_full Tumor Suppressor 4.1N/EPB41L1 is Epigenetic Silenced by Promoter Methylation and MiR-454-3p in NSCLC
title_fullStr Tumor Suppressor 4.1N/EPB41L1 is Epigenetic Silenced by Promoter Methylation and MiR-454-3p in NSCLC
title_full_unstemmed Tumor Suppressor 4.1N/EPB41L1 is Epigenetic Silenced by Promoter Methylation and MiR-454-3p in NSCLC
title_short Tumor Suppressor 4.1N/EPB41L1 is Epigenetic Silenced by Promoter Methylation and MiR-454-3p in NSCLC
title_sort tumor suppressor 4.1n/epb41l1 is epigenetic silenced by promoter methylation and mir-454-3p in nsclc
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251189/
https://www.ncbi.nlm.nih.gov/pubmed/35795202
http://dx.doi.org/10.3389/fgene.2022.805960
work_keys_str_mv AT yangqin tumorsuppressor41nepb41l1isepigeneticsilencedbypromotermethylationandmir4543pinnsclc
AT zhulin tumorsuppressor41nepb41l1isepigeneticsilencedbypromotermethylationandmir4543pinnsclc
AT yemao tumorsuppressor41nepb41l1isepigeneticsilencedbypromotermethylationandmir4543pinnsclc
AT zhangbin tumorsuppressor41nepb41l1isepigeneticsilencedbypromotermethylationandmir4543pinnsclc
AT zhanpeihe tumorsuppressor41nepb41l1isepigeneticsilencedbypromotermethylationandmir4543pinnsclc
AT lihui tumorsuppressor41nepb41l1isepigeneticsilencedbypromotermethylationandmir4543pinnsclc
AT zouwen tumorsuppressor41nepb41l1isepigeneticsilencedbypromotermethylationandmir4543pinnsclc
AT liujing tumorsuppressor41nepb41l1isepigeneticsilencedbypromotermethylationandmir4543pinnsclc